Global Hemoperfusion production Market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by the increasing incidence of overdose and specific intoxications, which are major causes for hemoperfusion treatment. The market is also driven by the increasing prevalence of autoimmune diseases and hepatic encephalopathy, which are other major causes for hemoperfusion treatment. The resin adsorption segment accounted for the largest share in 2018 due to its high efficiency in removing toxins from blood plasma and its low cost as compared to activated carbon adsorption. The activated carbon adsorption segment accounted for a small share in 2018 due to its higher cost as compared to resin adsorption but it has been gaining traction over time owing to its ability in removing toxins from blood plasma that cannot be removed by resin adsorption process alone. The global hemoperfusion production market can be classified on the basis of type into resin adsorption and activated carbon adsorptions; on application into overdose, specific intoxications, certain autoimmune diseases, hepatic encephalopathy; on region into North America (NA), Latin America (LA), Europe (EU), Asia Pacific (APAC) and Middle East & Africa (MEA).
Some Of The Growth Factors Of This Market:
- The increasing number of patients with chronic kidney disease and the need for hemodialysis is a major factor in the growth of the hemoperfusion production market.
- The increasing prevalence of cardiovascular diseases, which are often treated with hemodialysis, is also a major factor in the growth of this market.
- The aging population and an increase in chronic kidney disease cases are expected to drive demand for hemodialysis treatments, which will lead to increased demand for hemoperfusion production equipment and services over time.
- Increasing awareness about the benefits of hemodialysis treatments will also contribute to increased demand for hemoperfusion production equipment and services over time as more people seek treatment options that do not require long-term hospitalization or surgery.
- Technological advancements in medical devices such as dialyzers have led to improved efficiency and reduced costs, which has contributed to increased adoption rates among hospitals.
Industry Growth Insights published a new data on “Hemoperfusion production Market”. The research report is titled “Hemoperfusion production Market research by Types (Resin Adsorption, Activated Carbon Adsorption, Others), By Applications (Overdose, Specific Intoxications, Certain Autoimmune Diseases, Hepatic Encephalopathy, Others), By Players/Companies Jafron Biomedical, Baxter (Gambro), Biosun Medical, Toray Medical, Asahi-Kasei, Kaneka, Zibo Kangbei, Aier, Cytosorbents”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Hemoperfusion production Market Research Report
By Type
Resin Adsorption, Activated Carbon Adsorption, Others
By Application
Overdose, Specific Intoxications, Certain Autoimmune Diseases, Hepatic Encephalopathy, Others
By Companies
Jafron Biomedical, Baxter (Gambro), Biosun Medical, Toray Medical, Asahi-Kasei, Kaneka, Zibo Kangbei, Aier, Cytosorbents
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Hemoperfusion production Market Report Segments:
The global Hemoperfusion production market is segmented on the basis of:
Types
Resin Adsorption, Activated Carbon Adsorption, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Overdose, Specific Intoxications, Certain Autoimmune Diseases, Hepatic Encephalopathy, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Jafron Biomedical
- Baxter (Gambro)
- Biosun Medical
- Toray Medical
- Asahi-Kasei
- Kaneka
- Zibo Kangbei
- Aier
- Cytosorbents
Highlights of The Hemoperfusion production Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Resin Adsorption
- Activated Carbon Adsorption
- Others
- By Application:
- Overdose
- Specific Intoxications
- Certain Autoimmune Diseases
- Hepatic Encephalopathy
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hemoperfusion production Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hemoperfusion is a medical procedure in which blood is circulated through a machine that breaks the red blood cells and then re-infuses them into the patient's bloodstream.
Some of the major players in the hemoperfusion production market are Jafron Biomedical, Baxter (Gambro), Biosun Medical, Toray Medical, Asahi-Kasei, Kaneka, Zibo Kangbei, Aier, Cytosorbents.
The hemoperfusion production market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Hemoperfusion production Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Hemoperfusion production Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Hemoperfusion production Market - Supply Chain
4.5. Global Hemoperfusion production Market Forecast
4.5.1. Hemoperfusion production Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Hemoperfusion production Market Size (000 Units) and Y-o-Y Growth
4.5.3. Hemoperfusion production Market Absolute $ Opportunity
5. Global Hemoperfusion production Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Hemoperfusion production Market Size and Volume Forecast by Type
5.3.1. Resin Adsorption
5.3.2. Activated Carbon Adsorption
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Hemoperfusion production Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Hemoperfusion production Market Size and Volume Forecast by Application
6.3.1. Overdose
6.3.2. Specific Intoxications
6.3.3. Certain Autoimmune Diseases
6.3.4. Hepatic Encephalopathy
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Hemoperfusion production Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Hemoperfusion production Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Hemoperfusion production Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Hemoperfusion production Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Hemoperfusion production Demand Share Forecast, 2019-2026
9. North America Hemoperfusion production Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Hemoperfusion production Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Hemoperfusion production Market Size and Volume Forecast by Application
9.4.1. Overdose
9.4.2. Specific Intoxications
9.4.3. Certain Autoimmune Diseases
9.4.4. Hepatic Encephalopathy
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Hemoperfusion production Market Size and Volume Forecast by Type
9.7.1. Resin Adsorption
9.7.2. Activated Carbon Adsorption
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Hemoperfusion production Demand Share Forecast, 2019-2026
10. Latin America Hemoperfusion production Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Hemoperfusion production Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Hemoperfusion production Market Size and Volume Forecast by Application
10.4.1. Overdose
10.4.2. Specific Intoxications
10.4.3. Certain Autoimmune Diseases
10.4.4. Hepatic Encephalopathy
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Hemoperfusion production Market Size and Volume Forecast by Type
10.7.1. Resin Adsorption
10.7.2. Activated Carbon Adsorption
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Hemoperfusion production Demand Share Forecast, 2019-2026
11. Europe Hemoperfusion production Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Hemoperfusion production Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Hemoperfusion production Market Size and Volume Forecast by Application
11.4.1. Overdose
11.4.2. Specific Intoxications
11.4.3. Certain Autoimmune Diseases
11.4.4. Hepatic Encephalopathy
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Hemoperfusion production Market Size and Volume Forecast by Type
11.7.1. Resin Adsorption
11.7.2. Activated Carbon Adsorption
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Hemoperfusion production Demand Share, 2019-2026
12. Asia Pacific Hemoperfusion production Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Hemoperfusion production Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Hemoperfusion production Market Size and Volume Forecast by Application
12.4.1. Overdose
12.4.2. Specific Intoxications
12.4.3. Certain Autoimmune Diseases
12.4.4. Hepatic Encephalopathy
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Hemoperfusion production Market Size and Volume Forecast by Type
12.7.1. Resin Adsorption
12.7.2. Activated Carbon Adsorption
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Hemoperfusion production Demand Share, 2019-2026
13. Middle East & Africa Hemoperfusion production Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Hemoperfusion production Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Hemoperfusion production Market Size and Volume Forecast by Application
13.4.1. Overdose
13.4.2. Specific Intoxications
13.4.3. Certain Autoimmune Diseases
13.4.4. Hepatic Encephalopathy
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Hemoperfusion production Market Size and Volume Forecast by Type
13.7.1. Resin Adsorption
13.7.2. Activated Carbon Adsorption
13.7.3. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Hemoperfusion production Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Hemoperfusion production Market: Market Share Analysis
14.2. Hemoperfusion production Distributors and Customers
14.3. Hemoperfusion production Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Jafron Biomedical
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Baxter (Gambro)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Biosun Medical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Toray Medical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Asahi-Kasei
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Kaneka
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Zibo Kangbei
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Aier
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Cytosorbents
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook